女性胸主动脉腔内修复术后不良心脏重构及降压需求增加
本研究回顾性纳入101例接受TEVAR或开放手术的胸主动脉瘤或夹层患者,评估性别特异性心脏重构和降压需求差异。女性TEVAR患者术后12、24、36个月降压药物需求显著更高,左室肥厚恶化更常见;男性无差异。TEVAR独立预测更高降压需求(IRR 1.48),开放手术与更低左室肥厚恶化风险相关(OR 0.11)。
要点
- 女性TEVAR术后降压药需求显著高于开放手术,12-36个月均明显
- 女性TEVAR后左室肥厚恶化更常见,左室射血分数变化无差异
- 男性中TEVAR与开放手术在心脏重构和降压需求上无显著差异
核心结论
- 女性TEVAR患者较开放手术出现更严重不良心脏重构和更高降压需求,男性无此差异。
研究设计与样本
- 回顾性队列研究,2015年1月至2022年1月共671例成人胸主动脉瘤或夹层患者,101例符合纳入标准(完整3年降压药和≥1年超声随访)。
主要发现
- 女性TEVAR术后12、24、36个月降压药物需求显著高于开放手术(P < 0.05)。
- 女性TEVAR后左室肥厚恶化更常见(P < 0.05),左室射血分数变化、卒中、心肌梗死和1年死亡率组间相似。
- 多变量分析中TEVAR独立预测更高降压需求(IRR 1.48;95% CI 1.27-1.73;P < 0.001)。
- 开放手术与更低左室肥厚恶化风险相关(OR 0.11;95% CI 0.01-0.63;P = 0.012)。
- 男性患者中TEVAR与开放手术无显著差异。
临床怎么用
- 女性TEVAR术后应加强血压监测和降压药物管理,并关注左室肥厚进展。
- 考虑性别特异性内移植物尺寸选择,并研发更顺应性的内移植物以减少长期心脏不良反应。
局限性
- 回顾性设计,样本量较小(101例),仅女性中观察到差异,男性结果可能受样本量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) has largely replaced open surgical repair (OSR) for many thoracic aortic pathologies due to lower perioperative morbidity and mortality. However, the increased aortic stiffness imparted by stent grafts may have long-term cardiovascular consequences, particularly among women. The purpose of this study is to evaluate sex-specific differences in cardiac remodeling and antihypertensive requirements following TEVAR compared with OSR. METHODS: A retrospective review was conducted of 671 adult patients who underwent TEVAR or OSR for thoracic aortic aneurysm or dissection between January 2015 and January 2022. Of these, 101 patients met inclusion criteria, with complete 3-year antihypertensive medication and ≥1-year echocardiographic follow-up data. Primary outcomes included changes in left ventricular ejection fraction (LVEF), left ventricular hypertrophy (LVH), and antihypertensive medication requirements. Multivariable Poisson generalized estimating equation and logistic regression models were used to identify factors associated with medication escalation and cardiac remodeling. RESULTS: Among female patients, TEVAR was associated with significantly greater antihypertensive medication requirements at 12, 24, and 36 months postoperatively (P < 0.05) compared with OSR. Worsening LVH occurred more frequently after TEVAR (P < 0.05), whereas changes in LVEF, rates of stroke, myocardial infarction, and 1-year mortality were similar between groups. In multivariable analysis, TEVAR independently predicted higher antihypertensive requirements (incidence rate ratio (IRR) 1.48; 95% CI, 1.27-1.73; P < 0.001), while OSR was associated with significantly lower odds of worsening LVH compared with TEVAR (OR 0.11; 95% CI, 0.01-0.63; P = 0.012). No significant differences were observed between TEVAR and OSR among male patients. CONCLUSION: Female patients undergoing TEVAR demonstrated greater adverse cardiac remodeling and higher antihypertensive requirements than those undergoing OSR. These findings suggest that sex-related differences in aortic stiffness and device oversizing may contribute to poorer long-term remodeling outcomes in women, underscoring the need for sex-specific endograft sizing and development of more compliant endografts.
引用
- Yuan K, Ock C, Helenowski I, et al. Female Sex is Associated with Adverse Cardiac Remodeling and Increased Antihypertensive Requirements After Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2026. PMID: 42269913. doi:10.1016/j.avsg.2026.05.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。